Abstract:Microarray expression profiling has become a valuable tool in the evaluation of the genetic consequences of metabolic disease. Although 3′-biased gene expression microarray platforms were the first generation to have widespread availability, newer platforms are gradually emerging that have more up-to-date content and/or higher cost efficiency. Deciphering the relative strengths and weaknesses of these various platforms for metabolic pathway-level analyses can be daunting. We sought to determine the practical strengths and weaknesses of four leading commercially available expression array platforms relative to biologic investigations, as well as assess the feasibility of cross-platform data integration for purposes of biochemical pathway analyses. Methods: Liver RNA from B6.Alb/cre,Pdss2loxP/loxP mice having primary coenzyme Q deficiency was extracted either at baseline or following treatment with an antioxidant/antihyperlipidemic agent, probucol. Target RNA samples were prepared and hybridized to Affymetrix 430 2.0, Affymetrix Gene 1.0 ST, Affymetrix Exon 1.0 ST, and Illumina Mouse WG-6 expression arrays. Probes on all platforms were re-mapped to coding sequences in the current version of the mouse genome. Data processing and statistical analysis were performed by R/Bioconductor functions, and pathway analyses were carried out by KEGG Atlas and GSEA. Results: Expression measurements were generally consistent across platforms. However, intensive probe-level comparison suggested that differences in probe locations were a major source of inter-platform variance. In addition, genes expressed at low or intermediate levels had lower inter-platform reproducibility than highly expressed genes. All platforms showed similar patterns of differential expression between sample groups, with ‘steroid biosynthesis’ consistently identified as the most down-regulated metabolic pathway by probucol treatment. Conclusions: This work offers a timely guide for metabolic disease investigators to enable informed end-user decisions regarding choice of expression microarray platform best-suited to specific research project goals. Successful cross-platform integration of biochemical pathway expression data is also demonstrated, especially for well-annotated and highly expressed genes. However, integration of gene-level expression data is limited by individual platform probe design and the expression level of target genes. Cross-platform analyses of biochemical pathway data will require additional data processing and novel computational bioinformatics tools to address unique statistical challenges.

A Comparative Study of Mouse Hepatic and Intestinal Gene Expression Profiles under PPAR<i>α</i>Knockout by Gene Set Enrichment Analysis

A comparative study of mouse hepatic and intestinal gene expression profiles under PPAR knockout by gene set enrichment analysis

A Meta-Analysis Study of Gene Expression Datasets in Mouse Liver under PPARα Knockout.

Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonists

Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.

Identification of High-Copper-responsive Target Pathways in Atp7b Knockout Mouse Liver by GSEA on Microarray Data Sets.

Comparative Gene Expression Analysis in Mouse Models for Identifying Critical Pathways in Mammary Gland Development

Species Differences between Mouse and Human PPARα in Modulating the Hepatocarcinogenic Effects of Perinatal Exposure to a High-Affinity Human PPARα Agonist in Mice

Relationship Between Hepatic Phenotype and Changes in Gene Expression in Cytochrome P450 Reductase (POR) Null Mice.

Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways.

Comparative Analysis of MTF-1 Binding Sites Between Human and Mouse

A comparative analysis of liver transcriptome suggests divergent liver function among human, mouse and rat

Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse hepatocytes

Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD<sub>82</sub> Cell Line

Human Peroxisome Proliferator-activated Receptor Α (pparα) Supports the Induction of Peroxisome Proliferation in PPARα-deficient Mouse Liver

Identification of PPAR‐related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking

Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARα in primary human hepatocytes

PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice

Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice

Pathway-based Genome-Wide Association Analysis Identified the Importance of RHO Pathway for Height in Chinese

Bioinformatics Analysis on Regulatory Mechanism of Peroxisome Proliferator-activated Receptor-γ Gene on Lipid Metabolism